Home NDC 52652-5001 Katerzia
Product NDC 52652-5001
11-digit product format 526525001
Labeler code 52652
Product ID 52652-5001_461e8d10-1805-e107-e063-6294a90aa288
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Amlodipine
Dosage form SUSPENSION
Route ORAL
Labeler Azurity Pharmaceuticals, Inc.
Application NDA211340
Marketing category NDA
Marketing start 2019-08-15
Substance AMLODIPINE BENZOATE
Active strength 1 mg/mL
Pharmacologic classes Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N211340-001 KATERZIA AMLODIPINE BENZOATE EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08
Orange Book patents# Current patent rows page 1 of 1 · 18 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N211340-001 KATERZIA EQ 1MG BASE/ML SOLUTION / ORAL RLD, RS 2019-07-08 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N211340-001 KATERZIA EQ 1MG BASE/ML SOLUTION / ORAL RLD, RS 2019-07-08 b00525d2431f…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N211340-001 KATERZIA EQ 1MG BASE/ML SUSPENSION / ORAL RLD, RS 2019-07-08 cb3db0bc1861…
Observed Orange Book patent history# Patent history page 1 of 11 · 434 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N211340-001 10894039 2037-10-06 U-3 2021-02-16 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211340-001 10894039 2037-10-06 U-185 2021-02-16 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211340-001 10952998 2037-10-06 Drug product 2021-03-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211340-001 10959991 2037-10-06 U-39 2021-04-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211340-001 10959991 2037-10-06 U-158 2021-04-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211340-001 11364230 2037-10-06 Drug product 2022-06-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211340-001 11471409 2037-10-06 U-3447 2022-10-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211340-001 11471409 2037-10-06 U-3448 2022-10-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211340-001 11484498 2037-10-06 Drug product 2022-11-04 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211340-001 11701326 2037-10-06 Drug product 2023-07-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211340-001 11918685 2037-10-06 U-3447 2024-03-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211340-001 11918685 2037-10-06 U-3448 2024-03-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211340-001 12053461 2037-10-06 Drug product 2024-08-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211340-001 12336984 2037-10-06 U-3447 2025-06-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211340-001 12336984 2037-10-06 U-3448 2025-06-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211340-001 12383498 2037-10-06 Drug product 2025-10-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211340-001 10695329 2037-10-16 Drug product 2020-07-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211340-001 10799453 2039-04-11 Drug product 2020-11-02 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N211340-001 10894039 2037-10-06 U-3 2021-02-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211340-001 10894039 2037-10-06 U-185 2021-02-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211340-001 10952998 2037-10-06 Drug product 2021-03-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211340-001 10959991 2037-10-06 U-39 2021-04-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211340-001 10959991 2037-10-06 U-158 2021-04-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211340-001 11364230 2037-10-06 Drug product 2022-06-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211340-001 11471409 2037-10-06 U-3447 2022-10-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211340-001 11471409 2037-10-06 U-3448 2022-10-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211340-001 11484498 2037-10-06 Drug product 2022-11-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211340-001 11701326 2037-10-06 Drug product 2023-07-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211340-001 11918685 2037-10-06 U-3447 2024-03-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211340-001 11918685 2037-10-06 U-3448 2024-03-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211340-001 12053461 2037-10-06 Drug product 2024-08-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211340-001 12336984 2037-10-06 U-3447 2025-06-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211340-001 12336984 2037-10-06 U-3448 2025-06-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211340-001 12383498 2037-10-06 Drug product 2025-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211340-001 10695329 2037-10-16 Drug product 2020-07-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211340-001 10799453 2039-04-11 Drug product 2020-11-02 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211340-001 10894039 2037-10-06 U-3 2021-02-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211340-001 10894039 2037-10-06 U-185 2021-02-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211340-001 10952998 2037-10-06 Drug product 2021-03-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211340-001 10959991 2037-10-06 U-39 2021-04-15 31067a03dcf5…
Additional Listing Data#
Finished product Yes
Brand name base Katerzia
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength AMLODIPINE BENZOATE 1 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination XD75TQ8A2P Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2184120 Internal RxNorm lookup 2184126 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 52652-5001-1 Katerzia 150 mL in 1 BOTTLE SUSPENSION 150 7 52652-5001-1 Katerzia 1 in 1 CARTON SUSPENSION 1 7
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 52652-5001 KATERZIA (AMLODIPINE) SUSPENSION [AZURITY PHARMACEUTICALS, INC.] 6 Current NDC, Legacy NDC, 2 package rows 20230719_df673a4d-acb8-444c-a472-c87ab8cbd366.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 52652-5001-1 52652500101 1 BOTTLE in 1 CARTON (52652-5001-1) / 150 mL in 1 BOTTLE 1 bottle 2019-08-15 0000-00-00 No No Current